Zapraszamy do zapoznania się z naszymi publikacjami.
- 2016 – EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures
- 2016 – Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- 2016 – Witamina D3 a upadki – ze strony „Postępy Nauk Medycznych”
- 2016 – Spożycie wapnia z dietą u osób starszych – przegląd literatury – ze strony „Postępy Nauk Medycznych”
- 2016 – The role of calcium supplementation in healthy musculoskeletal ageing
- 2016 – Poszerzenie kryteriów rozpoznania osteoporozy – ze strony „Postępy Nauk Medycznych”
- 2016 – Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- 2016 – Relationship between total hip (TH) BMD T-score and incidence of nonvertebral fracture (NVFX) with up to 10 years of Denosumab (Dmab) treatment
- 2015 – Możliwości implementacji Fracture Liaison Service w warunkach polskich w świetle wizyty w Glasgow Western Infirmary
- 2015 – Analiza kosztoefektywności leczenia złamań osteoporotycznych w powiązaniu z algorytmem FRAX na próbie populacji Polski
- 2015 – A 24-month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density:Results From the ADAMO Trial
- 2015 – Relationship Between Total Hip BMD T-Score and Incidence of Nonvertebral Fracture with up to 8 Years of Denosumab Treatment
- 2014 – Przyczyny upadków i urazów po upadkach u kobiet powyżej 50 roku życia żyjących samodzielnie w Krakowie
- 2014 – Skuteczne zapobieganie złamaniom osteoporotycznym
- 2014 – EFFECT OF EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: FIVE-YEAR RESULTS FROM THE FREEDOM EXTENSION
- 2014 – EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION
- 2014 – Codziennie zdajesz egzamin z medycyny – pytania przygotował Prof. Edward Czerwiński
- 2013 – STRONTIUM RANELATE IMPROVES OSTEOARTHRITIS SYMPTOMS COMPARED TO PLACEBO IN PATIENTS WITH KNEE OA – THE SEKOIA STUDY
- 2013 – European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF): Poster Presentation Abstracts
- 2013 – European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF) : Oral Communication Abstracts
- 2013 – Epidemiology and Economic Burden of Osteoporosis in Poland
- 2013 – Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- 2013 – The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
- 2013 – Clinical Impact of Osteoporotic Fractures
- 2012 – Zasady profilaktyki, rozpoznawania i leczenia osteoporotycznych złamań kości
- 2012 – Sex- and Age-related Changes of Trabecular Bone of Tibia in Growing Domestic Geese (Anser domesticus)
- 2012 – TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR SIX YEARS WITH DENOSUMAB: THREE-YEAR RESULTS FROM THE FREEDOM EXTENSION
- 2012 – Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib
- 2012 – Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
- 2012 – Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
- 2012 – The Effect of Six Years of Denosumab Treatment on New Vertebral and Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Results from the FREEDOM Extension Trial
- 2012 – Five Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the First Two Years of the FREEDOM Extension
- 2012 – A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
- 2012 – Denosumab treatment for 6 years in postmenopausal women with osteoporosis: The first 3 years of the freedom extension
- 2012 – A Randomized Open-Label Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates
- 2012 – Effects of Denosumab on Bone Mineral Density (BMD) and Bone Resorption Marker in Men With Low BMD Compared With Men With Prostate Cancer Receiving Androgen Deprivation Therapy and Women with Postmenopausal Osteoporosis (PMO)
- 2011 – Computer-generated radiological imagery of the structure of the spongious substance in the postnatal development of the tibiotarsal bones of the Peking domestic duck (Anas platyrhynchos var. domestica)
- 2011 – Safety Observations From Denosumab Long-term Extension and Cross-over Studies in Postmenopausal Women With Osteoporosis.
- 2011 – Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib
- 2011 – New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungar
- 2011 – DYLEMATY W OCENIE SKUTECZNOŚCI I BEZPIECZEŃSTWA LEKÓW ANTYRESORPCYJNYCH W BADANIACH KLINICZNYCH
- 2011 – OCENA PRZYDATNOŚCI TESTU “TANDEM WALK” ORAZ “TIMED UP AND GO” W OCENIE RYZYKA UPADKÓW U PACJENTÓW Z OSTEOPOROZĄ
- 2011 – WPŁYW RANELINIANU STRONTU NA PRZEBUDOWĘ KOŚCI W OSTEOPOROZIE
- 2011 – DENOSUMAB A BISFOSFONIANY; PODOBIEŃSTWA I RÓŻNICE
- 2011 – WYSTĘPOWANIE ZŁAMAŃ W POPULACJI MAŁOPOLSKI W OBSERWACJI 10-LETNIEJ A PROGNOZA RYZYKA METODĄ FRAX-PL
- 2011 – Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
- 2011 – LONG-TERM DENOSUMAB TREATMENT IN POST-MENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION
- 2011 – IN ESTIMATING FALL RISK IN OSTEOPOROTIC PATIENTS
- 2011 – Evaluation of FRAX to characterise fracture risk in Poland
- 2011 – Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
- 2011 – Denosumab Therapy in Postmenopausal Women with Osteoporosis: Results from the First Two Years of the Freedom Trial Extension
- 2011 – A Phase 3 Study of the Efficacy and Safety of Denosumab in Men With Low Bone Mineral Density: Design of the ADAMO Trial
- 2011 – FIVE-YEAR DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMAN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION
- 2011 – New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungar
- 2011 – BMD IN POSTMENOPAUSAL WOMAN WITH NEPHROLITHIASIS: 5-10 YEAR OBSERVATIONS
- 2011 – DELAYED UNION AFTER ATYPICAL SUBTROCHANTERIC FRACTURE UNDER ALENDRONATE TREATMENT: CASE REPORT
- 2011 – Atypical subtrochanteric fractures after long-term bisphosphonate therapy
- 2011 – Five Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the First Two Years of the FREEDOM Extension
Publikacje z 2010 roku
Publikacje z 2008 roku
Publikacje z 2006 roku
Publikacje z 2004 roku
Publikacje z 2002 roku
Publikacje z 1996 roku
Publikacje z 2009 roku
Publikacje z 2007 roku
Publikacje z 2005 roku
Publikacje z 2003 roku
Publikacje z 1995 roku
